Clinical Trial Update: Nafamostat Efficacy in Phase 3 Registrational CRRT Study [NA]

View source ↗

Summary

A Phase 3 registrational trial evaluating nafamostat efficacy in continuous renal replacement therapy for acute kidney injury is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Nafamostat (nafamostat mesylate)

Snippet

Sponsor: Talphera, Inc | Conditions: Acute Kidney Injury | NA | Status: RECRUITING